(Total Views: 702)
Posted On: 09/17/2020 5:49:26 AM
Post# of 151830
“ CytoDyn Submits its Top-line Report from its Phase 2 COVID-19 Trial to the U.S. FDA and Requests Emergency Use Approval” This was 8/17 y’all it preceded Naders statement of 9/2!
This is what I read and forwarded to fellow investors.
This is what I read and forwarded to fellow investors.


Scroll down for more posts ▼